GPX4 and neoplasm: Experimental studies showed that the GPX4 protein expression level was significantly decreased in tumor cells treated with RSL3, accompanied by mitochondrial membrane potential collapse, ROS surge, and iron ion metabolism imbalance, which all point to the typical phenotype of ferroptosis [57,59].